…The trials did not establish a mortality benefit. Consequently, the decision to prescribe colchicine requires attention to the balance between reduction in ischaemic events and…

…did not eliminate it. Angiographic restenosis—defined in the source material as follow up diameter stenosis greater than 50%—occurred in 20–30% of patients…

…someone syringes an ear that did not need syringing. The second commonest is that the syringing is performed on a tympanic membrane that was already…

…do not affect the management of cardiac arrest. Recurrent VT or VF after ROSC in a patient with a coronary risk profile should lead to…

…and a systemic steroid given early [2,3]. Grading Grade the severity by the most serious finding. A patient does not have to meet every…

…death, and among those who did, only a minority had a reduced value — the majority of sudden cardiac deaths occur in patients with preserved LVEF…

…Some patient groups have a two to three fold greater prevalence of asymptomatic atherosclerotic cardiovascular disease (ASCVD) than the general population. The evidence for premature…

…in the fifth decade of life in several family members. Imaging studies did not reveal structural cardiac abnormalities, nor coronary artery disease. Another male patient…

…delaying time to treatment. History taking, physical examination, ECG and laboratory tests are the cornerstones of management of patients with chest pain. A 12 lead…

…issued a consensus statement (refer to MacFarlane et al) and in 2016 Patton et al did likewise (refer to Patton et al). Surprisingly, the definition…